Developmental DNA demethylation is a determinant of neural stem cell identity and gliogenic competence.
Ian C MacArthurLiyang MaCheng-Yen HuangHrutvik BhavsarMasako SuzukiMeelad M DawlatyPublished in: Science advances (2024)
DNA methylation is extensively reconfigured during development, but the functional significance and cell type-specific dependencies of DNA demethylation in lineage specification remain poorly understood. Here, we demonstrate that developmental DNA demethylation, driven by ten-eleven translocation 1/2/3 (TET1/2/3) enzymes, is essential for establishment of neural stem cell (NSC) identity and gliogenic potential. We find that loss of all three TETs during NSC specification is dispensable for neural induction and neuronal differentiation but critical for astrocyte and oligodendrocyte formation, demonstrating a selective loss of glial competence. Mechanistically, TET-mediated demethylation was essential for commissioning neural-specific enhancers in proximity to master neurodevelopmental and glial transcription factor genes and for induction of these genes. Consistently, loss of all three TETs in embryonic NSCs in mice compromised glial gene expression and corticogenesis. Thus, TET-dependent developmental demethylation is an essential regulatory mechanism for neural enhancer commissioning during NSC specification and is a cell-intrinsic determinant of NSC identity and gliogenic potential.
Keyphrases
- stem cells
- transcription factor
- dna methylation
- gene expression
- circulating tumor
- genome wide
- cell free
- single molecule
- neuropathic pain
- cell fate
- genome wide identification
- spinal cord injury
- binding protein
- multidrug resistant
- skeletal muscle
- spinal cord
- nucleic acid
- metabolic syndrome
- copy number
- human health
- mesenchymal stem cells